
.png?width=1800&height=1156&name=website_landing_page_mobile_banner%20(2).png)
ICH E6(R3) Annex 2: Is Your Clinical Trial Operations Team Ready for 2027?
Tuesday, December 15, 2026 · 10:30 AM – 11:30 AM EST
CH E6(R3) Annex 2 takes effect in the EU on January 15, 2027. Join Cloudbyz for a practical readiness check covering what changes for decentralized trials, pragmatic trials and real-world data, what inspectors are likely to look for, and how to prioritize the work before the deadline.
Why This Matters
Annex 2 adds good clinical practice considerations for trials that use decentralized elements, pragmatic designs and real-world data. It builds on the E6(R3) principles and Annex 1 already in force in the EU since July 2025.
The biggest shift for sponsors and CROs is oversight. When visits move to patients' homes, data comes from devices and local clinics, and study drug ships directly to participants, accountability stays where it was. Sponsors and investigators still need to show they are in control, and the records need to prove it.
Awareness is high, but action is still catching up: 87% of stakeholders are familiar with ICH E6(R3), and 19% have taken meaningful action (Avoca 2025 State of the Industry Report). Studies with EU sites need to meet the January 15 date, wherever the sponsor is based.
What Can You Expect
- What Annex 2 adds: considerations for trials with decentralized elements, pragmatic designs and real-world data sources, and how they build on the E6(R3) principles already in force.
- Oversight when work leaves the site: delegation, vendor and home health oversight, and how sponsors show they stay in control.
- Data integrity and essential records: what your records should show when data comes from devices, patients' homes, local labs and real-world sources.
- A proportionate, risk-based approach: applying quality by design to decentralized and pragmatic trials without over-engineering.
- A readiness checklist: the processes, systems and documents to review before January 15, and where a unified CTMS and eTMF helps.
- A live demo: oversight and essential records in Cloudbyz CTMS and eTMF.
Attendees can also book a 20-minute Annex 2 readiness review with the Cloudbyz team.
Who Should Attend
- Clinical operations leaders and study managers at sponsors and CROs
- Clinical quality assurance and GCP compliance teams
- TMF and clinical document management owners
- Vendor management and outsourcing teams
- Teams running or planning decentralized, hybrid or pragmatic trials, or trials that use real-world data
- US-based sponsors and CROs with sites in the EU
Contact line
Can't attend live? Register anyway and we'll send you the recording. For questions, contact info@cloudbyz.com.
Thank you for attending our live webinar! The on-demand video is currently in production and will be available soon.
Register for the Webinar